OpenResearchAlpha

bioRxiv · 6 Nov 2026

CD300f is required for efficient lipid handling during cuprizone-induced demyelination

Gemma Manich, Natalia Rego, Elvira de Frutos, Paula Sanchez-Molina, Beatriz Almolda, Ruben Lopez-Vales, Berta Gonzalez, Bernardo Castellano, Hugo Peluffo, Natalia Lago

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Microglia play a crucial role in central nervous system homeostasis and response to demyelination, yet the mechanisms that coordinate the sensing and processing of myelin-derived lipids remain poorly understood. CD300f is a lipid-sensing innate immune receptor expressed by myeloid cells that has been implicated in tissue damage sensing, phagocytosis, and lipid metabolism. Here, we investigated the role of CD300f in the cuprizone-induced demyelination model. Using CD300f-deficient mice, we demonstrate exacerbated demyelination, increased lipid droplet accumulation, impaired microglial responses, and reduced remyelination accompanied by motor coordination deficits. Bulk RNA sequencing of the corpus callosum at the peak of demyelination revealed enrichment of homeostatic, disease-associated (DAM), and foamy microglial signatures, together with increased expression of genes involved in lysosomal function, phagocytosis, inflammation, and lipid metabolism. Notably, these transcriptional changes were associated with marked lipid droplet accumulation in microglia and enrichment of microglial states previously linked to chronic demyelinating lesions. These findings suggest that CD300f is required for efficient handling of myelin-derived lipids and for microglial metabolic adaptation during demyelination. Our study identifies CD300f as a critical regulator of microglial function and lipid homeostasis and highlights this receptor as a potential therapeutic target in demyelinating diseases.

Neuroscience

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (10)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
CD300f is required for efficient lipid handling during cuprizone-induced demyelination - QAI OpenResearch